Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Skylight Health Group Inc V.SLHG.H

Alternate Symbol(s):  SLHGF

Healthcare Technology Cannabis
Skylight Health Group Inc. is a Canada-based healthcare services and technology company. The Company operates a Florida-based primary care health network comprised of physical practices providing a range of services from primary care, sub-specialty, allied health and laboratory/diagnostic testing. The Company is focused on helping small and independent practices shift from a traditional fee-for... see more

Recent & Breaking News (TSXV:SLHG.H)

CB2 Insights Adds Former Johnson & Johnson Executive as Director

GlobeNewswire July 31, 2019

Major UK Medical Cannabis Project Selects Canadian Company’s Data Technology Platform

Dave Jackson July 22, 2019

CB2 Insights Offers Exclusive Platform for UK’s Largest Cannabis Pilot

Stockhouse Editorial July 18, 2019

CB2 Insights Selected by Drug Science as Research Technology Platform for the UK's Largest Medical Cannabis Pilot

GlobeNewswire July 18, 2019

Successful 1st Test for CB2’s Cannabis Evaluation Platform

Stockhouse Editorial July 9, 2019

Premier Health and CB2 Insights Move to Second Phase of Primary Care Physician Tools for Medical Cannabis Evaluation

GlobeNewswire July 9, 2019

CB2 Insights and Premier Health Group Move to Second Phase of Primary Care Physician Tools for Medical Cannabis Evaluations

GlobeNewswire July 9, 2019

CB2 Acquires New Jersey Medical Cannabis Group

Stockhouse Editorial June 26, 2019

CB2 Insights Expands Clinical Division into New Jersey with the Asset Acquisition of New Jersey Alternative Medicine Clinics

GlobeNewswire June 25, 2019

CB2 Insights Announces Annual General & Special Meeting of Shareholders and Corporate Update

GlobeNewswire June 24, 2019

Building the Cannabis Data Big Pharma Needs

Dave Jackson May 31, 2019

CB2 Insights Posts Strong Growth in Clinical Revenue and Drives Operating Efficiencies in Q1 2019

GlobeNewswire May 30, 2019

CB2 Insights to Host Q12019 Earnings Call on May 31, 2019

GlobeNewswire May 27, 2019

CB2 Insights Announces Ticker Symbol Change on OTCQB

GlobeNewswire May 17, 2019

CB2 Insights Inc., Tools to Help Physicians Prescribe Medical Cannabis, CEO Clip Video

Newsfile May 3, 2019

CB2 Insights Expands Board with Teladoc Executive Marc Adelson,  Appoints David Danziger as Chairman and Adopts Advance Notice Bylaw

GlobeNewswire May 2, 2019

CB2 Insights Announces FY2018 Financial Results After Transformative Year

GlobeNewswire April 30, 2019

CB2 Insights to Host FY2018 Earnings Call on May 1, 2019

GlobeNewswire April 26, 2019

CB2 Insights Completes Acquisition of Cannabis Evaluation Clinics in Arizona and Colorado

GlobeNewswire April 10, 2019

CB2 Insights Acquires Multi-Location Medical Cannabis Clinic

Stockhouse Editorial April 4, 2019